AR049176A1 - Vacuna que comprende un pestivirus atenuado - Google Patents

Vacuna que comprende un pestivirus atenuado

Info

Publication number
AR049176A1
AR049176A1 ARP050102032A ARP050102032A AR049176A1 AR 049176 A1 AR049176 A1 AR 049176A1 AR P050102032 A ARP050102032 A AR P050102032A AR P050102032 A ARP050102032 A AR P050102032A AR 049176 A1 AR049176 A1 AR 049176A1
Authority
AR
Argentina
Prior art keywords
vdvb
pestiviruses
vaccine
attenuated
pestivirus
Prior art date
Application number
ARP050102032A
Other languages
English (en)
Spanish (es)
Inventor
Gregor Meyers
Andreas Ege
Christiane Meyer
Freyburg Martina Von
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34967522&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR049176(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of AR049176A1 publication Critical patent/AR049176A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24361—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ARP050102032A 2004-05-19 2005-05-18 Vacuna que comprende un pestivirus atenuado AR049176A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004025452A DE102004025452A1 (de) 2004-05-19 2004-05-19 Vakzine enthaltend BVDV

Publications (1)

Publication Number Publication Date
AR049176A1 true AR049176A1 (es) 2006-07-05

Family

ID=34967522

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP050102032A AR049176A1 (es) 2004-05-19 2005-05-18 Vacuna que comprende un pestivirus atenuado
ARP160101219A AR104448A2 (es) 2004-05-19 2016-04-28 Una composición que comprende un pestivirus atenuado de dvb

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP160101219A AR104448A2 (es) 2004-05-19 2016-04-28 Una composición que comprende un pestivirus atenuado de dvb

Country Status (26)

Country Link
EP (1) EP1751276B9 (enExample)
JP (2) JP5006782B2 (enExample)
KR (1) KR100908798B1 (enExample)
CN (2) CN103352030B (enExample)
AR (2) AR049176A1 (enExample)
AT (1) ATE420949T1 (enExample)
AU (1) AU2005243488B2 (enExample)
BR (1) BRPI0510396B1 (enExample)
CA (1) CA2561719C (enExample)
CY (4) CY1109036T1 (enExample)
DE (2) DE102004025452A1 (enExample)
DK (1) DK1751276T5 (enExample)
ES (1) ES2321210T3 (enExample)
FR (3) FR15C0044I2 (enExample)
HU (2) HUS1500033I1 (enExample)
LU (3) LU92749I2 (enExample)
ME (1) ME01119B (enExample)
MX (1) MXPA06013298A (enExample)
NL (3) NL300743I1 (enExample)
NZ (1) NZ552088A (enExample)
PL (1) PL1751276T3 (enExample)
PT (1) PT1751276E (enExample)
RS (1) RS50753B9 (enExample)
SI (1) SI1751276T1 (enExample)
UY (1) UY28905A1 (enExample)
WO (1) WO2005111201A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7179473B2 (en) 1998-06-05 2007-02-20 Boehringer Ingelheim Vetmedica Gmbh Attenuated pestiviruses
US7135561B2 (en) 2001-09-06 2006-11-14 Boehringer Ingelheim Vetmedica Gmbh Infectious bovine viral diarrhea virus clone
US20090068223A1 (en) 2005-11-15 2009-03-12 Boehringer Ingelheim Vetmedica, Inc. Combination vaccine comprising an attenuated bovine viral diarrhea virus
CL2007002704A1 (es) 2006-09-22 2008-05-30 Intervet Int Bv Mutante de un pestivirus de una cepa citopatogenica con deleciones en la region codificante de la proteina npro del virus; vacuna que la comprende; y su uso para proteger al ganado vacuno contra la infeccion con un pestivirus tipo silvestre.
CL2008003202A1 (es) 2007-10-29 2009-11-27 Boehringer Ingelheim Vetmedica Inc Composicion inmunogenica que comprende bacterias vivas de mycoplasma bovis atenuada avirulenta.
UY31930A (es) * 2008-06-25 2010-01-29 Boheringer Ingelheim Pharma Kg Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante
SG10201506597RA (en) 2008-10-31 2015-10-29 Boehringer Ingelheim Vetmed Use Of Various Antigens Including Antigens From Mycoplasma Bovis In Multivalent Vaccine Composition
US8846054B2 (en) 2009-01-09 2014-09-30 Boehringer Ingelheim Vetmedica, Inc. Method of treating pregnant cows and/or heifers
UY32570A (es) 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
BR112013006515B1 (pt) 2010-09-21 2020-04-28 Intervet Int Bv vacina de combinação, e, método para a fabricação de uma vacina de combinação
JP6589159B2 (ja) * 2014-04-01 2019-10-16 共立製薬株式会社 新規ネコモルビリウイルス株、不活化ワクチン製剤、並びにネコモルビリウイルス感染症予防方法
ES2757927T3 (es) * 2014-05-23 2020-04-30 Boehringer Ingelheim Vetmedica Gmbh Virus de la peste porcina clásica (VPPC) recombinante que comprende sustituciones en el epítopo TAV de la proteína E2
CN105779499B (zh) * 2016-03-23 2019-11-19 江苏科技大学 重组杆状病毒和其应用及构建该重组杆状病毒的载体
CN107823639B (zh) * 2017-11-10 2020-10-02 齐鲁动物保健品有限公司 牛病毒性腹泻病毒灭活疫苗及其制备方法
CN108707190B (zh) * 2018-04-18 2021-07-13 中国科学院武汉病毒研究所 猪瘟病毒ns5b蛋白保真度突变体及其应用
CN114853912B (zh) * 2022-05-24 2023-06-13 中国农业科学院兰州兽医研究所 一种牛病毒性腹泻病毒e2-e0融合蛋白、制备方法及应用
CN115960847B (zh) * 2023-01-11 2024-06-14 青岛大学 小分子依赖的内含肽自剪接系统在制备减毒活疫苗中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6168942B1 (en) * 1998-11-10 2001-01-02 Pfizer Inc. Attenuated forms of bovine viral diarrhea virus
EP1104676A1 (en) * 1999-11-30 2001-06-06 Boehringer Ingelheim Vetmedica Gmbh Safe attenuated bovine viral diarrhea viruses for use in pregnant cows
CA2363493C (en) * 2000-11-22 2006-06-06 Xuemei Cao Attenuated forms of bovine viral diarrhea virus
DE10143813A1 (de) * 2001-09-06 2003-04-10 Boehringer Ingelheim Vetmed Infektiöser Rindervirusdiarrhoe-Virusklon

Also Published As

Publication number Publication date
JP5562316B2 (ja) 2014-07-30
FR15C0043I1 (fr) 2015-07-24
AU2005243488B2 (en) 2011-07-07
WO2005111201A1 (en) 2005-11-24
CA2561719A1 (en) 2005-11-24
CN1989240A (zh) 2007-06-27
CA2561719C (en) 2015-01-27
UY28905A1 (es) 2005-12-30
FR15C0042I1 (fr) 2015-07-24
NL300743I2 (enExample) 2016-01-26
ME01119B (me) 2013-03-20
LU92749I2 (fr) 2015-11-02
AU2005243488A1 (en) 2005-11-24
EP1751276B9 (en) 2020-05-27
DK1751276T3 (da) 2009-05-18
CN103352030B (zh) 2018-08-10
RS50753B9 (sr) 2020-08-31
BRPI0510396A (pt) 2007-11-13
CY2015023I2 (el) 2024-02-16
EP1751276B1 (en) 2009-01-14
MXPA06013298A (es) 2007-05-07
PT1751276E (pt) 2009-02-24
AR104448A2 (es) 2017-07-19
DK1751276T5 (da) 2020-07-20
BRPI0510396B1 (pt) 2020-08-18
DE602005012381D1 (de) 2009-03-05
NL300744I1 (enExample) 2016-01-26
LU92747I2 (fr) 2015-11-02
KR100908798B1 (ko) 2009-07-22
LU92748I2 (fr) 2015-11-02
FR15C0043I2 (fr) 2016-05-27
HUS1500033I1 (hu) 2015-07-28
NL300744I2 (enExample) 2016-01-26
CY2015021I2 (el) 2023-11-15
CY2015022I1 (el) 2020-05-29
CY1109036T1 (el) 2014-07-02
NZ552088A (en) 2009-10-30
FR15C0042I2 (fr) 2018-11-16
CY2015021I1 (el) 2020-05-29
ATE420949T1 (de) 2009-01-15
NL300745I2 (enExample) 2016-01-26
SI1751276T1 (sl) 2009-06-30
JP5006782B2 (ja) 2012-08-22
CN103352030A (zh) 2013-10-16
CN1989240B (zh) 2013-07-31
CY2015022I2 (el) 2024-02-16
JP2012061001A (ja) 2012-03-29
ES2321210T3 (es) 2009-06-03
FR15C0044I2 (fr) 2016-05-27
CY2015023I1 (el) 2020-05-29
RS50753B (sr) 2010-08-31
DE102004025452A1 (de) 2006-01-19
KR20070012862A (ko) 2007-01-29
NL300743I1 (enExample) 2016-01-26
PL1751276T3 (pl) 2009-06-30
EP1751276A1 (en) 2007-02-14
ES2321210T9 (es) 2020-11-04
JP2007537740A (ja) 2007-12-27
NL300745I1 (enExample) 2016-01-26
FR15C0044I1 (fr) 2015-07-24
HUS1500031I1 (hu) 2019-11-28

Similar Documents

Publication Publication Date Title
NO20070551L (no) Vaksinesammensetninger og fremgangsmater for behandling av koronavirus infeksjon.
UY28905A1 (es) Pestivirus atenuados con al menos una mutación en las secuencias codificadoras de glicoproteína erns y de npro, preparación y composiciones
NO20061912L (no) Vaksinesammensetninger omfattende et interleukin 18 og saponin adjuvant system
AR072302A1 (es) Pestivirus atenuados. composicion inmunogenica. metodo.
IL202978A0 (en) West nile virus vaccine
WO2007117303A3 (en) Combination vaccine comprising an attenuated bovine viral diarrhea virus
WO2005116270A3 (en) Influenza virus vaccine composition and method of use
EA200701669A1 (ru) Композиции и способы лечения или предотвращения инфекций, вызванных вирусами семейства flaviviridae
BRPI0415883A (pt) compostos e composições de nucleosìdeo para o tratamento de infecções virais
NO20061911L (no) Immunogene sammensetninger
AR044696A1 (es) Composicion de vacunas
NO20052136L (no) Vaksine mot Hepatitt C-virus (HCV).
MX2013000242A (es) Tratamiento de enfermedades relacionadas con el virus de hepatitis c que usa hidroxicloroquina o una combinacion de hidroxicloroquina y un agente antiviral.
UY27798A1 (es) Inhibidores de la arn polimerasa dependiente de arn del virus de la hepatits c y composiciones y tratamientos que los usan.
ATE547118T1 (de) Rekombinanter koi-herpesvirus (khv) oder cyprinid-herpesvirus 3 (cyhv-3) und impfstoff zur prävention einer von khv/cyhv-3 bei cyprinus carpio carpio oder cyprinus carpio koi verursachten erkrankung
IL182440A0 (en) Subtype-matched inactivated whole virus vaccines for treating patients with hiv infection
MX2023012530A (es) Composición y metodos de vacuna adyuvada.
DE60331412D1 (de) Hiv-vakzine und anwendungsverfahren
TW200633995A (en) Andrographolide derivatives to treat viral infections
EA200301151A1 (ru) Вакцина против натуральной оспы
ECSP066805A (es) Compuestos silinano como inhibidores de cisteína proteasa
DE60325838D1 (de) Imidazoquinolinamine als adjuvantien für hiv dna vakzine
DE602006014720D1 (de) Immunstimulatorische kombination zur vorbeugung und behandlung von hepatitis c
MXPA04007491A (es) Tratamiento profilactico y terapeutico de infecciones y otras enfermedades con compuestos inmunoefectores.
CU23496A1 (es) Composición vacunal contra el virus de la hepatitis c

Legal Events

Date Code Title Description
FG Grant, registration